Rhonda Voskuhl, M.D. is a Professor of Neurology at the University of California, Los Angeles (UCLA), the Director of the UCLA Multiple Sclerosis Program, and holds the Jack H. Skirball Chair in MS Research. She is the Founding Neurologist for the UCLA Comprehensive Menopause Program and the UCLA Inventor for patents licensed by CleopatraRX for a brain protective menopause hormone treatment selected in Fall of 2025 as the #17 top invention by UCLA in the 21^st century. She is the PI of a National Institutes of Health R35 Research Program Award in Neuroscience (2023-2031). In 2024, Voskuhl received the John Dystel Prize in MS Research from the American Academy of Neurology. In 2023, she was awarded the Rachel Horne Prize in Women’s Health Research in MS from the European and American Committee for Research and Treatment in MS, and in 2018 received the Berlin Institute of Health (BIH) Excellence Award for Sex and Gender Aspects in Health Research. Dr. Voskuhl’s research focuses on the study of sex hormone and sex chromosome effects to discover neuroprotective treatments. She sees healthy women with cognitive issues of menopause as well as patients with MS in the UCLA Neurology Clinic. Dr. Voskuhl is Past-President of the Organization for the Study of Sex Differences (2020-2022).